It appears that donepzil (Aricept) and other Alzheimer drugs are NOT allowed for use during the Phase 2b/3 Blarcamesine trial according to the clinical trials.gov inclusion and exclusion criteria.
Not sure all understand this. Apparently no other drugs of any kind not mentioned on the clinical trials website are allowed(tic). This even though they were allowed in the previous trial, AND it states 3 months to make sure drugs are stabilized in one's system for this trial. Can you imagine the field day AF would have with this change! My gosh
Market Data 
Markets 
AI
